BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1666074)

  • 1. Study of feline leukemia virus immunity.
    Charreyre C; Pedersen NC
    J Am Vet Med Assoc; 1991 Nov; 199(10):1316-24. PubMed ID: 1666074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response of kittens after vaccination followed by exposure to feline leukemia virus-infected cats.
    Hawks DM; Legendre AM; Rohrbach BW; Sebring R; Chavez L; Chu HJ; Acree WM
    J Am Vet Med Assoc; 1991 Nov; 199(10):1463-9. PubMed ID: 1666104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
    Lutz H; Pedersen NC; Theilen GH
    Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
    Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
    J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
    Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
    J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of four test kits for feline leukemia virus antigen.
    Hawks DM; Legendre AM; Rohrbach BW
    J Am Vet Med Assoc; 1991 Nov; 199(10):1373-7. PubMed ID: 1666085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats.
    Gomes-Keller MA; Tandon R; Gönczi E; Meli ML; Hofmann-Lehmann R; Lutz H
    Vet Microbiol; 2006 Jan; 112(1):11-21. PubMed ID: 16303261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of humoral immunity tests in FeLV infected cats.
    Charreyre CE; Pedersen N
    Dev Biol Stand; 1990; 72():197-200. PubMed ID: 2178116
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy of three commercial feline leukemia virus vaccines against methylprednisolone acetate-augmented oronasal challenge exposure with virulent virus.
    Pedersen NC; Johnson L
    J Am Vet Med Assoc; 1991 Nov; 199(10):1453-5. PubMed ID: 1666102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.
    Snyder HW; Singhal MC; Hardy WD; Jones FR
    J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of localized feline leukemia virus infection in cats.
    Hayes KA; Rojko JL; Mathes LE
    Am J Vet Res; 1992 Apr; 53(4):604-7. PubMed ID: 1316726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Year two of follow-up evaluation of a randomized, blind field trial of a commercial feline leukemia virus vaccine.
    Scarlett JM; Pollock RV
    J Am Vet Med Assoc; 1991 Nov; 199(10):1431-2. PubMed ID: 1666098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine.
    Pedersen NC
    J Vet Intern Med; 1993; 7(1):34-9. PubMed ID: 8384261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection.
    Hines DL; Cutting JA; Dietrich DL; Walsh JA
    J Am Vet Med Assoc; 1991 Nov; 199(10):1428-30. PubMed ID: 1666097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a feline leukemia virus vaccine in a controlled natural transmission study.
    Lafrado LJ
    J Am Vet Med Assoc; 1994 Mar; 204(6):914-7. PubMed ID: 8188511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure.
    Legendre AM; Hawks DM; Sebring R; Rohrbach B; Chavez L; Chu HJ; Acree WM
    J Am Vet Med Assoc; 1991 Nov; 199(10):1456-62. PubMed ID: 1666103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of antibody infusion on pathogenesis of experimental feline leukemia virus infection.
    Haley PJ; Hoover EA; Quackenbush SL; Gasper PW; Macy DW
    J Natl Cancer Inst; 1985 Apr; 74(4):821-7. PubMed ID: 2985857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.